Schedule Update - effective 1 Dec 2007 (text extract)

This is the text extract for Schedule Update - effective 1 Dec 2007, browse documents here.

UPDATE

New Zealand Pharmaceutical Schedule

Effective 1 December 2007

Cumulative for September, October, November and December 2007 Section H cumulative for December 2007

Contents

Summary of PHARMAC decisions effective 1 December 2007 ...................... .3 Wider access to some Pharmaceutical Cancer Treatments ............................. 4 PHARMAC Schedule User Survey – Thank you ............................................... 5 Endorsements – do these need to be initialled by the prescriber? ................. 5 Tender News .................................................................................................. 6 Looking Forward ........................................................................................... 7 Sole Subsidised Supply products cumulative to December 2007 ................... 8 New Listings ................................................................................................ 17 Changes to Restrictions ............................................................................... 21 Changes to Subsidy and Manufacturer’s Price............................................. 27 Changes to General Rules............................................................................ 31 Changes to Section G: Safety Cap Medicines............................................... 32 Changes to Sole Subsidised Supply ............................................................. 32 Delisted Items ............................................................................................. 33 Items to be Delisted .................................................................................... 37 Section H changes to Part II ........................................................................ 41 Index ........................................................................................................... 42

Summary of PharmaC decisions

effeCtive 1 DeCember 2007 New listing (page 17) • Calcium gluconate (Mayne) inj 10%, 10 ml, 10 inj pack size • Erythromycin lactobionate (Erythrocin IV) inj 1 g • Saquinavir (Invirase) tab 500 mg – Special Authority – Hospital pharmacy [HP1] • Naproxen sodium (Sonaflam) tab 275 mg • Alprazolam (Arrow-Alprazolam) tab 250 µg, 500 µg and 1 mg – Retail pharmacy-Specialist – Month Restriction • Mitozantrone (Mitozantrone Ebewe) inj 2 mg per ml, 5 ml and 10 ml – PCT only – Specialist Changes to restriction (pages 21 – 22) • Oxaliplatin – amended Special Authority criteria • Paclitaxel – removal of Special Authority criteria • Vinorelbine – amended Special Authority criteria Decreased subsidy (page 27) • Cefoxitin sodium (Mayne) inj 1 g • Mitozantrone (Baxter) inj 1 mg for ECP • Loratadine (Apo-Loratadine) tab 10 mg • Ipratropium bromide (Atrovent Nasal Aqueous) aqueous nasal spray, 0.03%

Pharmaceutical Schedule - Update News

Wider access to some Pharmaceutical Cancer Treatments

Access to vinorelbine, oxaliplatin and paclitaxel will be widened from 1 December 2007. The Special Authority criteria will be removed completely from paclitaxel which means that it can be used for the treatment of all cancers, including relapsed germ cell cancer of the testis, taxane-relapsed ovarian cancer and node-negative early breast cancer. Access to vinorelbine has been widened to include early stage operable non-small cell lung cancer. Oxaliplatin access has been widened to include the treatment of stage III operable bowel cancer. Bowel cancer is the second most common type of cancer in New Zealand with approximately 2,300 new cases and

1,200 deaths from the disease each year. Widening access will see a further 1,000 people per year treated with oxaliplatin. Theses decisions represent an investment by DHBs of more than $31 million over five years, and will benefit some 1,500 patients with cancer every year.

Pharmaceutical Schedule - Update News

PHARMAC Schedule User Survey – Thank You

We would like to thank everyone who responded to the Pharmaceutical Schedule Users Questionnaire. Thank you to all who took the time to share their views on the Pharmaceutical Schedule. Colmar Brunton has been inundated with responses. The survey was posted to all Schedule subscribers last month with the November 2007 Update. Colmar Brunton is analysing the responses and will report back to PHARMAC next month. Two Mystery Weekends for two are up for grabs to those who participated. These will be randomly drawn and the successful winners will be announced next month.

Endorsements – do these need to be initialled by the prescriber?

An endorsement is text written by the prescriber on a prescription. An endorsement can be either hand written or computer generated on the prescription by the prescriber. The endorsement usually does not need to be initialled by the prescriber. If the endorsement is written (either by hand or computer generated) on the prescription by the prescriber at the time of prescribing then it does not need to be separately initialled by the prescriber. The only endorsement that must be initialled separately is the close control endorsement (see Close Control definition in Section A). Further, where an endorsement has been altered by the pharmacy, with the prescriber’s authorisation, then it must be initialled by the prescriber. Pharmacists are not eligible to endorse prescriptions.

tender News

Sole Subsidised Supply changes – effective 1 January 2008

Chemical Name Captopril Captopril Captopril Colestipol hydrochloride Colistin sulphomethate Dextrose with electrolytes Presentation; Pack size Tab 1.5 mg; 500 tab Tab 5 mg; 500 tab Tab 50 mg; 500 tab Sach 5 g; 0 sach Inj 150 mg; 1 inj Oral soln with electrolytes; 1000 ml OP Sole Subsidised Supply brand (and supplier) Apo-Captopril (Apotex) Apo-Captopril (Apotex) Apo-Captopril (Apotex) Colestid (Pfizer) Colistin-Link (Link) Pedialyte – Plain (Abbott) Pedialyte – Bubblegum (Abbott) Pedialyte – Fruit (Abbott) Arrow-Metformin (Arrow) Arrow-Metformin (Arrow) Apo-Oxybutynin (Apotex) Apo-Oxybutynin (Apotex) AFT (AFT) AFT (AFT)

Metformin hydrochloride Metformin hydrochloride Oxybutynin Oxybutynin Phenoxymethylpenicillin (Penicillin V) Phenoxymethylpenicillin (Penicillin V)

Tab 500 mg; 500 tab Tab 850 mg; 50 tab Tab 5 mg; 500 tab Oral liq 5 mg per 5 ml; 47 ml OP Grans for oral liq 15 mg per 5 ml; 100 ml Grans for oral liq 50 mg per 5 ml; 100 ml

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 January 2008 • Influenza vaccine (Vaxigrip, Fluvax) – new listings with access criteria • Thyroxine (Eltroxin) tab 50 µg and 100 µg – subsidy increase • Simvastatin (SimvaRex) tab 10 mg, 20 mg and 40 mg – subsidy decrease • Timolol maleate (Timoptol XE) eye drops 0.25% and 0.5% - subsidy decrease • Sodium chloride (Pharmacia) inj 0.9%, 20 ml – subsidy decrease Possible decisions for implementation 1 february 2008 • Lamotrigine (Mogine and Arrow-Lamotrigine) tab dispersible 25 mg, 50 mg, 100 mg and 200 mg – subsidy decrease • Clozapine (Clopine) tab 25 mg, 50 mg, 100 mg and 200 mg – subsidy decrease

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Acetazolamide Acipimox Acitretin Allopurinol Amitriptyline Amlodipine Apomorphine hydrochloride Amoxycillin

Presentation

Tab 50 mg Cap 50 mg Cap 10 mg & 5 mg Tab 100 mg & 00 mg Tab 10 mg, 5 mg & 50 mg Tab 5 mg & 10 mg Inj 10 mg per ml, 1 ml Cap 50 mg & 500 mg Grans for oral liq 15 mg per 5 ml Grans for oral liq 50 mg per 5 ml Inj 50 mg, 500 mg & 1 g Device Cream Tab 100 mg Tab 50 mg & 100 mg Inj 00 µg, 1 ml Inj 100 µg, 1 ml Eye drops 1% Metered aqueous nasal spray 50 µg Metered aqueous nasal spray 100 µg Scalp app 0.1% Crm 0.1% Oint 0.1% Tab 00 mg Tab 5 mg Eye drops 0.% Tab .5 mg & 10 mg Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP Cap 0.5 µg & 0.5 µg Tab dispersible .5 g Tab 1.5 g Tab 1.5 g Inj 50 mg Cap 50 mg Grans for oral liq 15 mg per 5 ml Inj 500 mg & 1 g

Brand Name Expiry Date*

Diamox Olbetam Neotigason Progout Amitrip Calvasc Mayne Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin Ibiamox Ortho Multichem Apo-Ascorbic Acid Loten AstraZeneca AstraZeneca Atropt Alanase Alanase Beta Scalp Beta Cream Beta Ointment Fibalip Lax-Tab AFT Alpha-Bromocriptine Marcain Isobaric Marcain Heavy ABM ABM Calcitriol-AFT Calci-Tab Effervescent Calci-Tab 500 Calci-Tab 00 Calcium Folinate Ebewe Ranbaxy Cefaclor Ranbaxy Cefaclor m-Cefazolin 008 008 008 008 008 008 009 010 009 008 008 008 009 009 009 008 009 009 008 008 010 008 008 010 009 009 008

Applicator Aqueous cream Ascorbic acid Atenolol Atropine sulphate

Beclomethasone dipropionate Betamethasone valerate

Bezafibrate Bisacodyl Brimonidine tartrate Bromocriptine mesylate Bupivicaine hydrochloride Calamine Calcitriol Calcium carbonate

Calcium folinate Cefaclor monohydrate Cefazolin sodium

008 010 008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Ceftriaxone sodium Cetirizine hydrochloride Cetomacrogol Chloramphenicol Chlorhexidine gluconate

Presentation

Inj 500 mg & 1 g Oral liq 1 mg per ml Tab 10 mg Crm BP Eye drops 0.5% Eye oint 1% Handrub 1% with ethanol 70% Mouthwash 0.% Soln 4% Tab 5 mg Tab 50 mg, 500 mg & 750 mg Grans for oral liq 15 mg per 5 ml Cap hydrochloride 150 mg Inj phosphate 150 mg per ml, 4 ml Crm 0.05% Scalp app 0.05% Oint 0.05% Tab 500 µg & mg TDDS .5 mg, 100 µg per day TDDS 5 mg, 00 µg per day TDDS 7.5 mg, 00 µg per day Tab 5 µg Tab 150 µg Inj 150 µg per ml, 1 ml Vaginal crm 1% with applicator(s) Crm 1% Tab 500 µg Powder for soln for oral use Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml Tab trimethoprim 80 mg and sulphamethoxazole 400 mg Tab 50 mg Inj 50 mg per ml, 1 ml Tab 50 mg Tab 50 mg Cap 5 mg & 50 mg Inj 500 mg Nasal spray 10 µg per dose

Brand Name Expiry Date*

AFT Allerid C Razene PSM Chlorsig Chlorsig Orion Orion Orion Hygroton Cipflox Klacid Dalacin C Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS- Catapres-TTS- Dixarit Catapres Catapres Clomazol Clomazol Colgout Enerlyte Trisul 008 008 2010 009 009 008 009 008 010 008 009 008 008 008

Chlorthalidone Ciprofloxacin Clarithromycin Clindamycin Clobetasol propionate

Clonazepam Clonidine

Clonidine hydrochloride

008

Clotrimazole Colchicine Compound electrolytes Co-trimoxazole

010 008 010 010 008

Cyclizine hydrochloride Cyclizine lactate Cyclophosphamide Cyproterone acetate Dantrolene sodium Desferrioxamine mesylate Desmopressin

Nausicalm Valoid (AFT) Cycloblastin Siterone Dantrium Mayne Desmopressin-PH&T

009 008 010 009 009 010 008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Dexamethasone sodium phosphate Diaphragm Dicloflenac sodium Didanosine (DDI) Dihydrocodeine tartrate Diphenoxylate hydrochloride with atropine sulphate Dipyridamole Docusate sodium Emulsifying ointment BP Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate Ethambutol hydrochloride Ethinyloestradiol Ethinyloestradiol with norethisterone

Presentation

Inj 4 mg per ml, 1 ml Inj 4 mg per ml, ml Range of sizes Tab EC 5 mg & 50 mg Tab long-acting 75 mg & 100 mg Cap 15 mg, 00 mg, 50 mg & 400 mg Tab long-acting 0 mg Tab .5 mg with atropine sulphate 5 µg Tab long-acting 150 mg Tab 50 mg & 10 mg Ointment Tab 5 mg, 10 mg & 0 mg Inj 500 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 00 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 400 mg Tab 10 µg Tab 5 µg with norethisterone 500 µg Tab 5 µg with norethisterone 1 mg Tab 5 µg with norethisterone 1 mg and 7 inert tab Tab 5 µg with norethisterone 500 µg and 7 inert tab Cap 50 mg & 100 mg Cap 50 mg & 500 mg Grans for oral liq 15 mg per 5 ml Grans for oral liq 50 mg per 5 ml Cap 50 mg, 150 mg & 00 mg Oint 950 µg, with fluocortolone pivalate 90 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 10 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1%

Brand Name Expiry Date*

Mayne Ortho All-flex & Ortho Coil Apo-Diclo Apo-Diclo SR Videx EC DHC Continus Diastop Pytazen SR Coloxyl AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin Myambutol New Zealand Medical and Scientific Brevinor 1 Brevinor 1/1 Brevinor 1/8 Norimin Vepesid Staphlex AFT AFT Pacific Ultraproct Ultraproct 008 009 009 009 008 009 009 008 008 008 008 008 009 009 009 008 008 009 010

Etoposide Flucloxacillin sodium

Fluconazole Fluocortolone caproate with fluocortolone pivalate and cinchocaine

008 010

Fluorometholone

Flucon

009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Fluphenazine decanoate

Presentation

Inj 1.5 mg per 0.5 ml, 0.5 ml Inj 5 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Tab 0.8 mg & 5 mg Crm % & Oint % Inj 40 mg per ml, ml Tab 80 mg Tab 5 mg Oral liq mg per ml Tab 500 µg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 50 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Tab 5 mg & 0 mg Powder 5 g Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous % and mineral oil Tab 10 mg Inj 0 mg Eye drops 0.% Eye drops 0.5% Oral liq 100 mg per 5 ml, 00 ml Tab 00 mg Tab 10 mg & 5 mg Tab .5 mg Cap 5 mg & 50 mg Nebuliser soln, 50 µg per ml, 1 ml Nebuliser soln, 50 µg per ml, ml Aerosol inhaler, 0 µg per dose CFC-free Tab long-acting 0 mg Cap 10 mg Cap 0 mg Cap 100 mg Shampoo % Eye drops 0.5% & 0.5%

Brand Name Expiry Date*

Modecate Modecate Modecate Apo-Folic Acid Foban Pfizer Apo-Gliclazide Minidiab Serenace Serenace Serenace Haldol Haldol Concentrate AstraZeneca Douglas m-Hydrocortisone Colifoam Locoid DP Lotn HC Gastrosoothe Buscopan Poly-Tears Methopt Fenpaed I-Profen Tofranil Napamide Rheumacin Ipratripium Steri-Neb Ipratripium Steri-Neb Atrovent Duride Isotane 10 Isotane 0 Sporanox Ketopine Betagan 008

Folic Acid Fusidic acid Gentamicin sulphate Gliclazide Glipizide Haloperidol

009 010 009 008 008 010 009 008 009 009 008 009 2010 008 008 008 010 008 009 009 008 010 008 009 009 010 008 010

Haloperidol decanoate Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil Hyoscine N-butylbromide Hypromellose Ibuprofen Imipramine hydrochloride Indapamide Indomethacin Ipratropium bromide

Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Levobunolol

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Levodopa with benserazide

Presentation

Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 0 ml Crm .5% with prilocaine .5%; 0 g OP Crm .5% with prilocaine .5%; 5 g Tab 5 mg, 10 mg & 0 mg Tab mg Oral liq 1 mg per ml Tab 1 mg & .5 mg Inj 49.% Liq 0.5% Shampoo 1% Tab 5 mg & 75 mg Tab .5 mg, 5 mg, 10 mg, 100 mg & 00 mg Enema 1 g per 100 ml Powder 1 g Tab .5 mg & 10 mg Inj 100 mg per ml, 5 ml Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 15 mg, 50 mg & 500 mg Tab long-acting 0 mg Tab 5 mg & 0 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj .5 mg per ml, 1 ml Inj 500 mg & 1 g

Brand Name Expiry Date*

Madopar .5 Madopar Dispersible Madopar 15 Madopar HBS Madopar 50 Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Lorapaed Ativan Mayne Derbac M A-Lices Ludiomil Provera Pentasa AFT Methoblastin Methotrexate Ebewe Methotrexate Ebewe Methotrexate Ebewe Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol 009 010 010 009 009 2010 010 009 010 009 009 009 008 010 009

Lignocaine hydrochloride

Lignocaine with prilocaine

010

Lisinopril Loperamide hydrochloride Loratadine Lorazepam Magnesium sulphate Malathion Maldison Maprotiline hydrochloride Medroxyprogesterone acetate Mesalazine Methadone hydrochloride Methotrexate

Methyldopa Methylphenidate hydrochloride

008 009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

009 009 008 008 009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Mexiletine hydrochloride Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

Presentation

Inj 5 mg per ml, ml Tab long-acting 00 mg Cap 50 mg Cap 50 mg & 00 mg Crm % Tab .5 mg & 5 mg Tab 00 µg Tab 150 mg & 00 mg Oral liq 1 mg per ml Oral liq mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 0 mg, 0 mg, 100 mg & 00 mg Tab immediate release 10 mg & 0 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Eye drops 0.1% Tab 50 mg Tab 500 mg Tab long-acting 750 mg Tab long-acting 1000 mg Inj .5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 50 mg & 500 mg Tab long-acting 0 mg Jelly % Tab 50 µg Tab 5 mg Tab 400 mg Tab 10 mg & 5 mg Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Oral liq 100,000 u per ml

Brand Name Expiry Date*

Pfizer Slow-Lopressor Metopirone Mexitil Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Naphcon Forte Noflam 250 Noflam 500 Naprosyn SR 750 Naprosyn SR 1000 AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Gynol II Noriday 8 Primolut-N Arrow-Norfloxacin Norpress Nilstat Nilstat Nilstat Nilstat 009 010 010 008 009 008 010 009 009 009 008 009 008 008 008 010 009 008 008 009 009 008 008 009 009 009 009

Morphine sulphate

009

Morphine tartrate Nadolol Naltrexone hydrochloride Naphazoline hydrochloride Naproxen

Neostigmine Nevirapine Nicotinic acid Nifedipine Nonoxynol-9 Norethisterone Norfloxacin Nortriptyline Nystatin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Ondansetron Oxycodone hydrochloride Oxytocin

Presentation

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj mg per ml, 5 ml Inj mg per ml, 10 ml Inj mg per ml, 10 ml Tab 500 mg Suppos 15 mg & 50 mg Oral liq 10 mg per 5 ml Oral liq 50 mg per 5 ml Tab 500 mg with 8 mg codeine Eye oint with soft white paraffin Tab 0 mg Tab 0.5 mg & 1 mg Tab 100 mg Cap potassium salt 50 mg Cap potassium salt 500 mg Eye drops 0.12% Eye drops 0.5%, 1%, %, 4% & % Oral drops 10% Tab long-acting 00 mg Inj 75 mg per ml, 10 ml Inj 150 mg per ml, 10 ml Tab 1 mg, .5 mg, 5 mg & 0 mg Cassette Inj 1.5 mega u Tab 10 mg & 5 mg Tab 50 mg Tab 5 mg, 10 mg & 0 mg Tab 10 mg with hydrochlorothiazide 1.5 mg Tab 20 mg with hydrochlorothiazide 1.5 mg Tab 00 mg Tab 00 mg

Brand Name Expiry Date*

Zofran Zofran Zydis OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Panadol Panadol Junior Parapaed Six Plus Parapaed Codalgin Laci-Lube Loxamine Permax Pexsig Cilicaine VK Cilicaine VK Prefrin Pilopt Coloxyl Span-K AstraZeneca AstraZeneca Apo-Prednisone MDS Quick Card Cilicaine Allersoothe Apo-Pyridoxine Accupril Accuretic 10 Accuretic 0 Q 00 Q 00 009 010 2010 009

Pamidronate disodium

008

Paracetamol

008

Paracetamol with codeine Paraffin liquid with soft white paraffin Paroxetine hydrochloride Pergolide Perhexiline maleate Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pilocarpine Poloxamer Potassium chloride

008 010 010 008 009 010 2010 008 008 009 008 008 009 008 008 009 008 008

Prednisone Pregnancy tests - HCG urine Procaine penicillin Promethazine hydrochloride Pyridoxine hydrochloride Quinapril Quinapril with hydrochlorothiazide

Quinine sulphate

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Presentation

Tab 150 mg & 00 mg Cap 150 mg Tab 150 mg & 00 mg Nebuliser soln 1 mg per ml, .5 ml Nebuliser soln mg per ml, .5 ml Oral liq mg per 5 ml Nebuliser soln, .5 mg with ipratropium bromide 0.5 mg Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% Eye drops % Tab 500 mg Tab EC 500 mg Liq Soln .% with triethanolamine lauryl sulphate and fluorescein sodium Tab 10 mg Tab 50 mg Tab 10 mg Tab 50 mg Crm & Oint 0.0% Dental Paste USP 0.1% Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate .5 mg and gramicidin 50 mcg per g Oint 1 mg with nystatin 100,000 u, neomycin sulphate .5 mg and gramicidin 50 µg per g Tab 15 µg Tab 50 µg Tab 00 mg Cap 5 mg & 50 mg Crm 10% Cap 00 mg Inj 50 mg per ml, 10 ml Tab long-acting 10 mg Inj 1 mg per ml, 1 ml Inj 1 mg per ml, ml

Brand Name Expiry Date*

Arrow Ranitidine Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin Apo-Selegiline AstraZeneca Ural Rex Cromolux Salazopyrin Salazopyrin EN Midwest Pinetarsol Normison Apo-Terbinafine Apo-Timol Apo-Thiamine Aristocort Oracort Kenacomb Kenacomb 008 010 009 009 010 009 009 009 010 009 008 009 010 008 008 008 009 009 008 009 008

Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terbinafine Timolol maleate Thiamine hydrochloride Triamcinolone acetonide Triamcinolone acetonide with gramicidin, neomycin and nystatin

Triazolam Trimethoprim Trimipramine maleate Urea Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vincristine sulphate

Hypam Hypam TMP Tripress Nutraplus Actigall Pacific Verpamil SR Mayne Mayne

008 008 008 008 008 008 008 009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Sole Subsidised Supply Products – cumulative to December 2007

Generic Name

Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone

Presentation

Tab (BPC cap strength) Tab, strong, BPC Purified for injection 20 ml Oint BP Cap 0 mg Tab 7.5 mg

Brand Name Expiry Date*

Healtheries Apo-B-Complex Multichem Multichem Zincaps Apo-Zopiclone 009 009 009 008 008 008

December changes are in bold type

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 December 2007

7 8 95 99 10 CALCIUM GLUCONATE ❋ Inj 10%, 10 ml ........................................................................ 1.40 ERYTHROMYCIN LACTOBIONATE Inj 1 g ....................................................................................... .50 SAQUINAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Tab 500 mg .......................................................................... 55.59 NAPROXEN SODIUM ❋ Tab 75 mg ............................................................................. .00 ALPRAZOLAM – Retail pharmacy – Specialist – Month Restriction Tab 50 µg .............................................................................. .5 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 µg .............................................................................. 4.0 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg ................................................................................. 7.85 ‡ Safety cap for extemporaneously compounded oral liquid preparations. MITOZANTRONE – PCT only – Specialist Inj mg per ml, 5 ml ............................................................ 110.00 Inj mg per ml, 10 ml .......................................................... 0.00 10 1 10 10 50 50 50 ✔ Mayne ✔ Erythrocin IV ✔ Invirase ✔ Sonaflam ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam

1 1

✔ Mitozantrone Ebewe ✔ Mitozantrone Ebewe

Effective 9 November 2007

44 ASPIRIN ❋ Tab 100 mg ............................................................................. .0 90 ✔ Ethics Aspirin EC

Effective 1 November 2007

RANITIDINE HYDROCHLORIDE – Only on a prescription ❋ Oral liq 150 mg per 10 ml – Subsidy by endorsement ................ 7.95 00 ml ✔ Peptisoothe Oral liquid is subsidised only for patients: 1) with oesophageal stricture, or ) in terminal care, or ) who are either too young or too old to swallow conventional tablets and the prescription is endorsed accordingly. Note: the cost of treatment with ranitidine oral liquid is higher than that of ranitidine tablets. Following the derestriction of access PHARMAC will be monitoring expenditure on ranitidine oral liquid more closely and may, subject to consultation and PHARMAC Board approval, restrict access again if the expenditure was to grow substantially. FERROUS SULPHATE ❋‡ Oral liq 150 mg per 5 ml ....................................................... 10.0 ASPIRIN ❋ Tab 100 mg ........................................................................... 1.8 500 ml 990 ✔ Ferodan ✔ Ethics Aspirin EC

7 44

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 November 2007 (continued)

47 51 SODIUM CHLORIDE Inj 0.9%, 0 ml ......................................................................... 7.8 DOXAZOSIN MESYLATE ❋ Tab mg ................................................................................. 4.81 ❋ Tab 4 mg ................................................................................. .7 RITONAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Oral liq 80 mg per ml ............................................................ 10.98 0 100 100 90 ml OP ✔ Multichem ✔ Apo-Doxazosin ✔ Apo-Doxazosin ✔ Norvir

95 104

METHADONE HYDROCHLORIDE a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets). d) For methadone hydrochloride oral liquid refer, page 159 ✔ AFT S29 Inj 10 mg per ml, 1 ml ............................................................ 5.00 10 QUETIAPINE Tab 5 mg ............................................................................. 0. Tab 100 mg ........................................................................... 41.5 Tab 00 mg ........................................................................... 70.88 Tab 00 mg ......................................................................... 119.5 ACETYLCYSTEINE – Hospital pharmacy [HP1]-Specialist Inj 00 mg per ml, 10 ml ...................................................... 17.0 (4.50) 90 90 90 90 10 Hospira ✔ Quetapel ✔ Quetapel ✔ Quetapel ✔ Quetapel

117

Effective 1 October 2007

5 7 MESALAZINE Suppos 1 g ............................................................................ 50.9 OMEPRAZOLE ❋ Cap 10 mg ............................................................................... .99 ❋ Cap 0 mg ............................................................................... 4.7 ❋ Cap 40 mg ............................................................................... 5.01 4 LACTULOSE – Only on a prescription ❋ Oral liq 10 g per 15 ml .............................................................. .5 8 8 8 8 ✔ Pentasa ✔ Dr Reddy’s Omeprazole ✔ Dr Reddy’s Omeprazole ✔ Dr Reddy’s Omeprazole ✔ Duphalac

1,000 ml

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 October 2007 (continued)

4 MACROGOL 50 – Special Authority see SA0891 – Retail pharmacy Powder 1.15 g, sachets – not more than 0 sachets per prescription.................................................. 18.14 0 ✔ Movicol ➽ SA0891 Special Authority for Subsidy Initial application by any relevant practitioner. Approvals valid for months where the patient has problematic constipation requiring intervention with a per rectal preparation despite an adequate trial of other oral pharmacotherapies including lactulose where lactulose is not contraindicated. Renewal from any relevant practitioner. Approvals valid for 1 months where the patient is compliant and is continuing to gain benefit from treatment. SIMVASTATIN – See prescribing guideline ❋ Tab 10 mg ............................................................................... .1 ❋ Tab 0 mg ............................................................................... .81 ❋ Tab 40 mg ............................................................................... 4.98 0 0 0 ✔ SimvaRex ✔ SimvaRex ✔ SimvaRex

IBUPROFEN – Additional subsidy by Special Authority see SA091 – Retail pharmacy ❋ Tab 00 mg ............................................................................. 1.0 0 (.84) CITALOPRAM HYDROBROMIDE ❋ Tab 0 mg ............................................................................... .50 MIDAZOLAM Inj 1 mg per ml, 5 ml .............................................................. 1.5 (14.73) Inj 5 mg per ml, ml .............................................................. 14.00 (19.64) 8 10

Brufen ✔ Citalopram - Rex

107 11

Pfizer 5 Pfizer

BUDESONIDE WITH EFORMOTEROL – Special Authority see SA088 – Retail pharmacy Aerosol inhaler 100 µg with eformoterol fumarate µg ..................................................................... 55.00 10 dose OP ✔ Symbicort Rapihaler Aerosol inhaler 00 µg with eformoterol fumarate µg ..................................................................... 0.00 10 dose OP ✔ Symbicort Rapihaler IPRATROPIUM BROMIDE Aqueous nasal spray, 0.0% .................................................. 1. 0 ml OP ✔ Apo-Ipravent

148 180

SOYA INFANT FORMULA – Special Authority see SA004 – Retail pharmacy Powder ..................................................................................... .4 900 g OP (19.57)

S Soy

New Listings - effective 17 September 2007

144 LORATADINE ❋ Tab 10 mg ............................................................................... .58 8.50 100 0 ✔ Loraclear Hayfever Relief ✔ Loraclear Hayfever Relief

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 September 2007

8 AZITHROMYCIN – Subsidy by endorsement a) Maximum of tab per prescription b) Available on a PSO c) Subsidised only if prescribed for patients with uncomplicated urethritis or cervicitis proven or presumed to be due to Chlamydia trachomatis and their sexual contacts and prescription or PSO is endorsed accordingly. Tab 500 mg ............................................................................. 9.90 OP ✔ Arrow-Azithromycin METHADONE HYDROCHLORIDE a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets). d) For methadone hydrochloride oral liquid refer, page 159 Tab 5 mg ................................................................................. .10 10 ✔ PSM OXYCODONE HYDROCHLORIDE a) Only on a controlled drug form b) No patient co-payment payable Inj 10 mg per ml, 1 ml ............................................................ 14.40 5 ✔ OxyNorm Inj 10 mg per ml, ml ............................................................ 8.80 5 ✔ OxyNorm ‡ Oral liq 5 mg per 5 ml ............................................................. 11.0 50 ml ✔ OxyNorm Prescribing Guideline Prescribers should note that oxycodone is significantly more expensive than long-acting morphine sulphate and clinical advice suggests that it is reasonable to consider this as a second-line agent to be used after morphine.

104

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 December 2007

14 OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 087 Inj 50 mg ............................................................................. 410.00 1 ✔ Eloxatin Inj 100 mg ........................................................................... 800.00 1 ✔ Eloxatin Inj 1 mg for ECP ....................................................................... 8.80 1 mg ✔ Baxter ➽ SA0900 0876 Special Authority for Subsidy Initial application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Either: 1 Both: 1.1 The patient has metastatic colorectal cancer; and 1.2 To be used for first or second line use as part of a combination chemotherapy regimen; or 2 Both: 2.1 The patient has Stage III (Duke’s C) colorectal* cancer; and 2.2 Adjuvant oxaliplatin to be given in combination with a fluoropyrimidine (fluorouracil or capecitabine) Renewal only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or The tumour has relapsed and requires re-treatment Note: Indications marked with * are Unapproved Indications, oxaliplatin is indicated for adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumour. 10 PACLITAXEL – PCT only – Specialist – Special Authority see SA0881 Inj 0 mg .............................................................................. 100.00 1 ✔ Taxol Inj 100 mg ........................................................................... .00 1 ✔ Taxol Inj 150 mg ........................................................................... 41.70 1 ✔ Paclitaxel Ebewe ✔ Paclitaxel Ebewe Inj 00 mg ........................................................................... 895.85 1 Inj 1 mg for ECP ....................................................................... .5 1 mg ✔ Baxter ➽ SA0881 Special Authority for Subsidy Initial application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Any of the following: 1 Both: 1.1 The patient has ovarian, fallopian* or primary peritoneal cancer*; and 1. Either: 1..1 Has not received prior chemotherapy; or 1.. Has received prior chemotherapy but have not previously been treated with taxanes; or The patient has metastatic breast cancer; or The patient has node-positive early breast cancer; or 4 Both 4.1 The patient has non small-cell lung cancer; and 4. Either: 4..1 Has advancing disease (stage IIIa or above); or 4.. Is receiving combined chemotherapy and radiotherapy; or 5 Both: 5.1 The patient has small-cell lung cancer*; and 5. Paclitaxel is to be used as second-line therapy. Renewal only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Both: continued... ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 December 2007 (continued)

continued... 1 The patient has metastatic breast cancer, non small-cell lung cancer, or small-cell lung cancer* and; Either: .1 The patient requires continued therapy; or . The tumour has relapsed and requires re-treatment. Note indications market with * are Unapproved Indications. 11 VINORELBINE – PCT only – Specialist – Special Authority see SA0901 088 Inj 10 mg per ml, 1 ml ............................................................ 4.00 1 ✔ Vinorelbine Ebewe Inj 10 mg per ml, 5 ml .......................................................... 10.00 1 ✔ Vinorelbine Ebewe Inj 1 mg for ECP ....................................................................... 4.9 1 mg ✔ Baxter ➽ SA0901 0883 Special Authority for Subsidy Initial application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Either Any of the following: 1 The patient has metastatic breast cancer; or The patient has non-small cell lung cancer (stage IIIa, or above); or 3 All of the following: 3.1 The patient has stage IB-IIIA non-small cell lung cancer; and 3.2 Vinorelbine is to be given as adjuvant treatment in combination with cisplatin; and 3.3 The patient has good performance status (WHO/ECOG grade 0-1). Renewal only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 1 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or The tumour has relapsed and requires re-treatment.

Effective 1 October 2007

5 55 HYDROCORTISONE ACETATE Rectal foam 10 %, CFC-Free (14 applications) ........................ 1.10 1.1 g OP ✔ Colifoam

METOPROLOL SUCCINATE ❋ Tab long-acting .75 mg – Higher subsidy of $6.20 per 30 with Endorsement ........................................... 5.0 (.0) ❋ Tab long-acting 47.5 mg – Higher subsidy of $7.80 per 30 with Endorsement ........................................... .50 (7.80) ❋ Tab long-acting 95 mg – Higher subsidy of $13.20 per 30 with Endorsement ....................................... 11.0 (1.0) ❋ Tab long-acting 190 mg – Higher subsidy of $21.00 per 30 with Endorsement ....................................... 0.5 (1.00) Additional subsidy by endorsement is available for patients who: a) were being prescribed metoprolol succinate prior to 1 October 2007; or b) have experienced a myocardial infarction. The prescription must be endorsed accordingly

0 Betaloc CR 0 Betaloc CR 0 Betaloc CR 0 Betaloc CR

Note – Repeats for Betaloc CR tab long-acting will be fully subsidised where the initial dispensing was before 1 October 2007.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 October 2007 (continued)

88 PHENOXYMETHYLPENICILLIN (PENICILLIN V) Grans for oral liq benzathine 15 mg per 5 ml – Available on a PSO ................................................................ 1.8 Grans for oral liq benzathine 50 mg per 5 ml – Available on a PSO ................................................................ 1.8

100 ml 100 ml

✔ AFT ✔ AFT

117

QUETIAPINE – Subsidy by endorsement Subsidised for: 1) patients presenting with first episode schizophrenia or related psychoses, or manic episodes associated with bipolar disorder; and 2) patients suffering from schizophrenia or related psychoses, or manic episodes associated with bipolar disorder, after a trial of an effective dose of risperidone that has been discontinued because of unacceptable side effects or inadequate response. Initial prescription must be written by a relevant specialist. Subsequent prescriptions may be written by a general practitioner. The prescription must be endorsed “certified condition”. Tab 5 mg ............................................................................. 4.0 0 ✔ Seroquel Tab 100 mg ........................................................................... 9.40 0 ✔ Seroquel Tab 00 mg ......................................................................... 158.7 0 ✔ Seroquel Tab 00 mg ......................................................................... 7.1 0 ✔ Seroquel MYCOPHENOLATE MOFETIL – Special Authority see SA0893 0798 – Hospital pharmacy [HP] Tab 500 mg ......................................................................... 0. 50 ✔ Cellcept Cap 50 mg ......................................................................... 0. 100 ✔ Cellcept Powder for oral liq 1 g per 5 ml – Subsidy by endorsement .... 85.00 15 ml OP ✔ Cellcept Mycophenolate powder for oral liquid is subsidised only for patients unable to swallow tablets and capsules, and when the prescription is endorsed accordingly. ➽ SA0893 0798 Special Authority for Subsidy Initial application only from a relevant specialist. Approvals valid without further renewal unless notified for applications meeting the following criteria: Any of the following: 1 Renal transplant recipient; or Heart transplant recipient; or 3 Patient has an organ transplant and has severe tophaceous gout making azathioprine unsuitable. Renewal only from a relevant specialist. Approvals valid without further renewal unless notified where the patient had a previous Special Authority approval and was receiving mycophenolate prior to 1 October 005.

150 150

ACICLOVIR ❋ Eye oint % – Retail pharmacy-Specialist................................. 7.5

4.5 g OP

✔ Zovirax

CIPROFLOXACIN Eye Drops 0.% – Retail pharmacy-Specialist prescription ...... 1.4 5 ml OP ✔ Ciloxan 1) Specialist must be an ophthalmologist. ) For treatment of bacterial keratitis or severe bacterial conjunctivitis resistant to chloramphenicol. DEXAMETHASONE WITH FRAMYCETIN AND GRAMICIDIN Retail Pharmacy – Specialist when used in the treatment of eye conditions. Ear/Eye drops 500 µg with framycetin sulphate 5 mg and gramicidin 50 µg per ml......................................................... 4.50 8 ml OP (9.7) GENTAMICIN SULPHATE Eye drops 0.% – Retail pharmacy-Specialist........................... 11.40 5 ml OP

150

Sofradex ✔ Genoptic

150

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 October 2007 (continued)

151 BETAXOLOL HYDROCHLORIDE – Retail pharmacy-Specialist ❋ Eye drops 0.5% .................................................................... 11.80 ❋ Eye drops 0.5% ........................................................................ 7.50 DEXAMETHASONE – Retail pharmacy-Specialist ❋ Eye oint 0.1% ........................................................................... 5.8 ❋ Eye drops 0.1 % ....................................................................... 4.50 5 ml OP 5 ml OP .5 g OP 5 ml OP ✔ Betoptic S ✔ Betoptic ✔ Maxidex ✔ Maxidex

151

DEXAMETHASONE WITH NEOMYCIN AND POLYMYXIN B SULPHATE – Retail pharmacy-Specialist ❋ Eye oint 0.1% with neomycin sulphate 0.5% and polymyxin B sulphate ,000 u per g ....................................................... 5.9 .5 g OP ✔ Maxitrol ❋ Eye drops 0.1% with neomycin sulphate 0.5% and polymyxin B sulphate ,000 u per ml ..................................................... 4.50 5 ml OP ✔ Maxitrol DICLOFENAC SODIUM ❋ Eye drops 1 mg per ml – Retail pharmacy-Specialist ................ 1.80 FLUOROMETHOLONE – Retail pharmacy-Specialist ❋ Eye drops 0.1% ........................................................................ 4.0 LEVOBUNOLOL – Retail pharmacy-Specialist ❋ Eye drops 0.5% ...................................................................... 7.00 ❋ Eye drops 0.5 % ....................................................................... 7.00 PREDNISOLONE ACETATE – Retail pharmacy-Specialist ❋ Eye drops 0.1% ...................................................................... 4.50 (7.5) ❋ Eye drops 1% ........................................................................... 4.50 (9.44) TOBRAMYCIN Eye oint 0.% – Retail pharmacy-Specialist.............................. 10.45 Eye drops 0.% – Retail pharmacy-Specialist........................... 11.48 BRIMONIDINE TARTRATE – Retail pharmacy-Specialist ❋ Eye Drops 0.% ........................................................................ 8.95 DORZOLAMIDE HYDROCHLORIDE – Retail pharmacy-Specialist ❋ Eye drops % ........................................................................... 9.77 (1.95) 5 ml OP 5 ml OP 5 ml OP 5 ml OP 5 ml OP Pred Mild 5 ml OP Pred Forte .5 g OP 5 ml OP 5 ml OP 5 ml OP Trusopt ✔ Tobrex ✔ Tobrex ✔ AFT ✔ Voltaren Ophtha ✔ Flucon ✔ Betagan ✔ Betagan

151 151 151

151

15 15

DORZOLAMIDE HYDROCHLORIDE WITH TIMOLOL MALEATE – Retail pharmacy-Specialist ❋ Eye drops % with timolol maleate 0.5% ................................. 18.50 5 ml OP ✔ Cosopt TIMOLOL MALEATE – Retail pharmacy-Specialist ❋ Eye drops 0.5% ...................................................................... .7 ❋ Eye drops 0.5%, gel forming ................................................... 5.0 ❋ Eye drops 0.5% ........................................................................ .9 ❋ Eye drops 0.5%, gel forming ..................................................... 5.78 5 ml OP .5 ml OP 5 ml OP .5 ml OP ✔ Apo-Timop ✔ Timoptol XE ✔ Apo-Timop ✔ Timoptol XE ✔ Combigan

BRIMONIDINE TARTRATE WITH TIMOLOL MALEATE – Retail pharmacy-Specialist ▲ Eye drops 0.% with timolol maleate 0.5% .............................. 18.50 5 ml OP

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 October 2007 (continued)

15 PILOCARPINE ❋ Eye drops % single dose – Special Authority see SA0895 011 – Hospital pharmacy [HP] ....................................................... 1.95 0 dose (.7) Minims ➽ SA0895 0121 Special Authority for Subsidy Initial application from any relevant practitioner medical practitioner. Approvals valid for years for applications meeting the following criteria: Either: 1 Patient has to use an unpreserved solution due to an allergy to the preservative; or Patient wears soft contact lenses. Note: Minims for a general practice are considered to be “tools of trade” and are not approved as special authority items. Renewal from any relevant practitioner medical practitioner. Approvals valid for years where the treatment remains appropriate and the patient is benefiting from treatment. FAT ➽ SA0899 0580 Special Authority for Subsidy Initial application — (Inborn errors of metabolism) only from a relevant specialist. Approvals valid for years where the patient has inborn errors of metabolism. Initial application — (Indications other than inborn errors of metabolism) only from a relevant specialist. Approvals valid for 1 year for applications meeting the following criteria: Any of the following: 1 failure to thrive where other high calorie products are inappropriate or inadequate; or 2 growth deficiency; or bronchopulmonary dysplasia; or 4 fat malabsorption; or 5 lymphangiectasia; or short bowel syndrome; or 7 infants with necrotising enterocolitis; or 8 biliary atresia. Renewal — (Inborn errors of metabolism) only from a relevant specialist or general practitioner on the recommendation of a relevant specialist. Approvals valid for years for applications meeting the following criteria: Both: 1 The treatment remains appropriate and the patient is benefiting from treatment; and General Practitioners must include the name of the specialist and date contacted. Renewal — (Indications other than inborn errors of metabolism) only from a relevant specialist or general practitioner on the recommendation of a relevant specialist. Approvals valid for 1 year for applications meeting the following criteria: Both: 1 The treatment remains appropriate and the patient is benefiting from treatment; and General Practitioners must include the name of the specialist and date contacted. PAEDIATRIC PRODUCTS ➽ SA0896 0590 Special Authority for Subsidy Initial application only from a relevant specialist. Approvals valid for 1 year for applications meeting the following criteria: All of the following: 1 infant aged one to eight six years; and Any of the following: .1 any condition causing malabsorption; or . failure to thrive; or continued... ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

continued...

Changes to Restrictions - effective 1 October 2007 (continued)

. increased nutritional requirements; and Either: .1 The product is to be used as a supplement (maximum 500 ml per day); or . The product is to be used as a complete diet. Renewal only from a relevant specialist or general practitioner on the recommendation of a relevant specialist. Approvals valid for 1 year for applications meeting the following criteria: All of the following: 1 The treatment remains appropriate and the patient is benefiting from treatment; and Either: .1 The product is to be used as a supplement (maximum 500 ml per day); or . The product is to be used as a complete diet; and General Practitioners must include the name of the specialist and date contacted.

Effective 1 September 2007

11 ONDANSETRON – Hospital pharmacy [HP] Retail pharmacy-Specialist a) Maximum of 1 tab per prescription; can be waived by Special Authority see SA0887 below b) Maximum of tab per dispensing; can be waived by Special Authority see SA0887 below c) Not more than one prescription per month; can be waived by Special Authority see SA0887 below. Tab 4 mg ............................................................................... 17.18 10 ✔ Zofran Tab disp 4 mg ........................................................................ 17.18 10 ✔ Zofran Zydis Tab 8 mg ............................................................................... .89 0 ✔ Zofran Tab disp 8 mg ........................................................................ 0.4 10 ✔ Zofran Zydis ➽ SA0887 Special Authority for Waiver of Rule Initial application from any relevant practitioner. Approvals valid for 12 months where patient is undergoing prolonged treatment with highly emetogenic chemotherapy and/or highly emetogenic radiation therapy for the treatment of malignancy. Renewal from any relevant practitioner. Renewals valid for 12 months where patient is undergoing prolonged treatment with highly emetogenic chemotherapy and/or highly emetogenic radiation therapy for the treatment of malignancy.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 December 2007

85 CEFOXITIN SODIUM – Hospital pharmacy [HP]-Specialist – Subsidy by endorsement (ê subsidy) Only if prescribed for dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 1 g ..................................................................................... 48.48 5 ✔ Mayne MITOZANTRONE – PCT only – Specialist (ê subsidy) Inj 1 mg for ECP ..................................................................... 1.98 LORATADINE (ê subsidy) ❋ Tab 10 mg ............................................................................... .58 (.70) IPRATROPIUM BROMIDE (ê subsidy) Aqueous nasal spray, 0.0% .................................................... . (11.79) ACETYLCYSTEINE – Hospital pharmacy [HP1]-Specialist (è price) Inj 00 mg per ml, 10 ml ...................................................... 17.0 (55.5) 1 mg 100 Apo-Loratadine 15 ml OP Atrovent Nasal Aqueous 10 Hospira ✔ Baxter

19 144

148

Effective 1 November 2007

5 POVIDONE IODINE (è price) Oint 10% ................................................................................... .88 (.7) a) Maximum of 100 g per prescription b) Only on a prescription POVIDONE IODINE (ê subsidy) Antiseptic soln 10% .................................................................. .0 5 g OP Betadine

5 8

500 ml

✔ Riodine

AZITHROMYCIN – Subsidy by endorsement (ê subsidy) a) Maximum of tab per prescription b) Available on a PSO c) Subsidised only if prescribed for patients with uncomplicated urethritis or cervicitis proven or presumed to be due to Chlamydia trachomatis and their sexual contacts and prescription or PSO is endorsed accordingly. Tab 500 mg ............................................................................. 9.90 OP (15.5) Zithromax METHADONE HYDROCHLORIDE (ê subsidy) a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets). d) For methadone hydrochloride oral liquid refer, page 159 Tab 5 mg ................................................................................. .10 10 (.78) Pallidone

104

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 November 2007 (continued)

108 DIAZEPAM (è subsidy) Rectal tubes 5 mg – Available on a PSO................................... 7.8 Rectal tubes 10 mg – Available on a PSO................................. .89 5 5 ✔ Stesolid ✔ Stesolid

175

GLUTEN FREE BREAD MIX – Special Authority see SA07 – Hospital pharmacy [HP] (è price) Powder .................................................................................... .9 1,000 g OP (5.4) NZB Low Gluten Bread Mix .51 (7.55) Horleys Bread Mix 4.77 (8.1) Bakels Gluten Free Health Bread Mix GLUTEN FREE FLOUR – Special Authority see SA07 – Hospital pharmacy [HP] (è price) Powder ..................................................................................... 5. ,000 g OP (1.0) Horleys Flour

175

Effective 1 October 2007

5 MESALAZINE (ê subsidy) Tab 400 mg – Retail pharmacy-Specialist ............................... 49.50 Suppos 500 mg ...................................................................... 5.0 DEXTROSE WITH ELECTROLYTES (ê subsidy) Soln with electrolytes................................................................. . (.44) .0 (.) COLESTIPOL HYDROCHLORIDE (è subsidy) Sachets 5 g ............................................................................ 1.17 CAPTOPRIL (è subsidy) ❋ Tab 1.5 mg .......................................................................... 10.40 ❋ Tab 5 mg ............................................................................. 1.40 ❋ Tab 50 mg ............................................................................. 19.00 DIGOXIN (è subsidy) ❋ Tab .5 µg – Available on a PSO ............................................. .94 ❋ Tab 50 µg – Available on a PSO ............................................ 15.1 ❋‡ Oral liq 50 µg per ml ............................................................ 1.0 100 0 500 ml OP Plasma-Lyte Oral 94 ml OP Pedialyte - Fruit 0 500 500 500 50 50 0 ml ✔ Colestid ✔ Apo-Captopril ✔ Apo-Captopril ✔ Apo-Captopril ✔ Lanoxin PG ✔ Lanoxin ✔ Lanoxin ✔ Asacol ✔ Asacol

48 51

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 October 2007 (continued)

55 METOPROLOL SUCCINATE (è price and alternate subsidy) ❋ Tab long-acting .75 mg – Higher subsidy of $.0 per 0 with Endorsement ......................................... 5.0 0 (.0) Betaloc CR ❋ Tab long-acting 47.5 mg – Higher subsidy of $7.80 per 0 with Endorsement ......................................... .50 0 (7.80) Betaloc CR ❋ Tab long-acting 95 mg – Higher subsidy of $1.0 per 0 with Endorsement ..................................... 11.0 0 (1.0) Betaloc CR ❋ Tab long-acting 190 mg – Higher subsidy of $1.00 per 0 with Endorsement ......................................... 0.5 0 (1.00) Betaloc CR Additional subsidy by endorsement is available for patients who: a) were being prescribed metoprolol succinate prior to 1 October 007; or b) have experienced a myocardial infarction. The prescription must be endorsed accordingly Note – Repeats for Betaloc CR tab long-acting will be fully subsidised where the initial dispensing was before 1 October 007. METOPROLOL TARTRATE (è subsidy) ❋ Tab 50 mg ............................................................................. 1.50 POVIDONE IODINE (ê price) Oint 10% .................................................................................. .88 POVIDONE IODINE (ê subsidy) Antiseptic soln 10% .................................................................. .0 OXYBUTYNIN (è subsidy) ❋ Oral liq 5 mg per 5 ml ............................................................. 50.40 THYROXINE (è subsidy) ❋ Tab 50 µg .............................................................................. 48.14 ‡ Safety cap for extemporaneously compounded oral liquid preparations. ❋ Tab 100 µg ............................................................................ 50.9 ‡ Safety cap for extemporaneously compounded oral liquid preparations. PHENOXYMETHYLPENICILLIN (PENICILLIN V) (è subsidy) Grans for oral liq 15 mg per 5 ml – Available on a PSO ............................................................. 1.8 Grans for oral liq 50 mg per 5 ml – Available on a PSO ............................................................. 1.8 100 5 g OP 500 ml ✔ Lopresor ✔ Betadine ✔ Betadine

55 5 5 7 80

47 ml OP ✔ Apo-Oxybutynin 1,000 1,000 ✔ Eltroxin ✔ Eltroxin

100 ml 100 ml

✔ AFT ✔ AFT

COLISTIN SULPHOMETHATE – Hospital pharmacy [HP]-Specialist – Subsidy by endorsement (è subsidy) Only if prescribed for dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 150 mg ............................................................................. 5.00 1 ✔ Colistin-Link FUSIDIC ACID (è subsidy) Tab 50 mg – Hospital pharmacy [HP]-Specialist ................. 4.7 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 1 ✔ Fucidin

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 October 2007 (continued)

117 QUETIAPINE (ê subsidy) Tab 5 mg ............................................................................. 4.0 Tab 100 mg ........................................................................... 9.40 Tab 00 mg ......................................................................... 158.7 Tab 00 mg ......................................................................... 7.1 0 0 0 0 ✔ Seroquel ✔ Seroquel ✔ Seroquel ✔ Seroquel ✔ Taxol ✔ Taxol ✔ Baxter ✔ Betaferon

PACLITAXEL – PCT only – Specialist – Special Authority SA0881 (ê subsidy) Inj 0 mg ................................................................................ 90.00 1 Inj 100 mg ........................................................................... 99.70 1 Inj 1 mg for ECP ....................................................................... .9 1 mg INTERFERON BETA-1-BETA – Special Authority SA0855 (ê subsidy) Inj 8 million iu per 1 ml ....................................................... 170. 15

140

Effective 1 September 2007

9 METFORMIN HYDROCHLORIDE (ê subsidy) ❋ Tab 500 mg ............................................................................. 9.75 ❋ Tab 850 mg ............................................................................. 8.00 500 50 ✔ Metomin ✔ Metomin

WATER (ê subsidy) 1) On a prescription or Practitioner’s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or ) On a bulk supply order; or ) When used in the extemporaneous compounding of eye drops. Purified for inj 5 ml – Available on a PSO ................................... 9.1 50 ✔ AstraZeneca Purified for inj 10 ml – Available on a PSO ............................... 10.8 50 ✔ AstraZeneca MALATHION (ê subsidy) Liq 0.5%.................................................................................... 4.99 (5.80) HYDROCORTISONE BUTYRATE (è subsidy) Scalp lotn 0.1% ........................................................................ 7.5 NITROFURANTOIN (è subsidy) ❋ Tab 50 mg ............................................................................. 17.0 ❋ Tab 100 mg ........................................................................... 9.40 LITHIUM CARBONATE (è subsidy) Tab long-acting 400 mg ......................................................... 15.45 PHENYLEPHRINE HYDROCHLORIDE (è subsidy) ❋ Eye drops 0.1% ...................................................................... 4.47 00 ml AFT 100 ml OP ✔ Locoid 100 100 100 15 ml OP ✔ Nifuran ✔ Nifuran ✔ Priadel ✔ Prefrin

7 9

11 154

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to General Rules

Effective 1 November 2007

The functions of PHARMAC are to perform the following, within the amount of funding provided to it in the Pharmaceutical Budget or to DHBs from their own budgets for the use of pharmaceuticals in their hospitals, as applicable, and in accordance with its annual plan and any directions given by the Minister (Section 10 of the Crown Entities Act): a) to maintain and manage a pharmaceutical schedule that applies consistently throughout New Zealand, including determining eligibility and criteria for the provision of subsidies; b) to manage incidental matters arising out of (a), including in exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the pharmaceutical schedule; c) to engage as it sees fit, but within its operational budget, in research to meet its objectives as set out in Section 47(a) of the Act; d) to promote the responsible use of pharmaceuticals; e) to manage the purchasing of any or all pharmaceuticals, whether used either in a hospital or outside it, on behalf of DHBs; f) any other functions given to PHARMAC by or under any enactment or authorised by the Minister. The policies and criteria set out in the Pharmaceutical Schedule and PHARMAC’s Operating Policies and Procedures arise out of, and are designed to help PHARMAC achieve and perform, PHARMAC’s objective and functions under the Act. However PHARMAC may, having regard to its public law obligations, depart from the strict application of those policies and criteria in certain exceptional cases where it considers this necessary or appropriate in the proper exercise of its statutory discretion and to give effect to its objective and functions, particularly with respect to: • Determining eligibility and criteria for the provision of subsidies: and • In exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the Pharmaceutical Schedule. 14 “Hospital Pharmacy-Specialist Prescription” means that the Community Pharmaceutical is not eligible for Subsidy unless it is supplied by a hospital or pharmacy contracted to the Funder to dispense as a hospital pharmacy: a) to an Outpatient; and b) on a Prescription signed by a Specialist. For the purposes of this definition, a “specialist” means a doctor who holds a current annual practicing certificate and who satisfies the criteria set out in paragraphs (a) or (b) or (c) of the definitions of Specialist below. “Retail Pharmacy-Specialist Prescription” means that the Community Pharmaceutical is only eligible for Subsidy if it is supplied on a Prescription, or Practitioner’s Supply Order, signed by a Specialist. For the purposes of this definition, a “specialist” means a doctor who holds a current annual practicing certificate and who satisfies the criteria set out in paragraphs (a) or (b) or (c) of the definitions of Specialist below. “Special Authority” means that the Community Pharmaceutical or Pharmaceutical Cancer Treatment is only eligible for Subsidy or additional Subsidy for a particular person if an application meeting the criteria specified in the Schedule has been approved, and the valid Special Authority number is present on the prescription.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Section G: Safety Cap Medicines

Effective 1 September 2007

OXYCODONE HYDROCHLORIDE Oral liq 5 mg per 5 ml .....................OxyNorm

Changes to Sole Subsidised Supply

Effective 1 December 2007

For the list of new Sole Subsidised Supply products effective 1 December 007 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 8-1.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 December 2007

7 59 TRIPOTASSIUM DICITRATOBISMUTHATE Tab 10 mg ........................................................................... 8.00 ADRENALINE Inj 1 in 1,000, 1 ml – Available on a PSO ................................ 1.50 90.00 CETOMACROGOL ❋ Cream BP ................................................................................. .80 (4.5) MALATHION Liq 0.5% ................................................................................... 4.99 (5.80) CONDOMS WITHOUT SPERMICIDE ❋ Condoms, proprietary – Available on a PSO ............................... 1.4 (5.70) SODIUM CITRO-TARTRATE ❋ Grans eff 4 g sachets ............................................................... 1.0 (.40) Note – the 28 pack size of Ural will continue to be available fully subsidised. 11 5 50 500 g IPW 00 ml AFT 1 R Superfeucht 8 ✔ Ural ✔ De-nol ✔ AstraZeneca ✔ AstraZeneca

IBUPROFEN – Additional subsidy by Special Authority see SA091 – Retail pharmacy ❋ Tab 400 mg ............................................................................. 1.78 50 (7.0) Brufen ❋ Tab long-acting 800 mg ........................................................... .01 0 (18.4) Brufen Retard Note – the 30 pack size of Brufen tab 400 mg and Brufen Retard tab long-acting 800 mg will continue to be available partially subsidised.. THIORIDAZINE HYDROCHLORIDE Tab 100 mg ........................................................................... 17.14 CHARCOAL ❋ Oral liq 50 g per 00 ml – Only on a PSO ................................. 19.95 90 ✔ Aldazine

117 155 15

00 ml OP ✔ Carbosorb

FAT SUPPLEMENT – Special Authority see SA0580 – Hospital pharmacy [HP] Emulsion (neutral) .................................................................. 15.8 50 ml OP ✔ Calogen Emulsion (strawberry) ............................................................ 15.8 50 ml OP ✔ Calogen RENAL ORAL FEED KCAL/ML – Special Authority see SA0587 – Hospital pharmacy [HP] Liquid ........................................................................................ .88 7 ml OP ✔ Nepro (vanilla) PREMATURE BIRTH FORMULA – Special Authority see SA00 – Hospital pharmacy [HP] Powder ..................................................................................... 0.98 10 g OP ✔ Similac Special Care 7.41 400 g OP ✔ SLBW Gold

170 179

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 November 2007

99 TIAPROFENIC ACID – Additional subsidy by Special Authority see SA091 – Retail pharmacy ❋ Cap long-acting 00 mg ............................................................ .77 5 (17.51) Surgam SA

Effective 1 October 2007

77 97 105 TESTOSTERONE ENANTHATE – Retail pharmacy-Specialist Inj long-acting 250 mg - prefilled syringe ................................ 45.00 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] Inj ........................................................................................... 75.00 MORPHINE SULPHATE a) Only on a controlled drug form b) No patient co-payment payable Suppos 5 mg........................................................................... 17.74 Suppos 10 mg ........................................................................ 19.14 Suppos 0 mg ........................................................................ 0.1 Suppos 0 mg ........................................................................ 1.9 DIAZEPAM Inj 5 mg per ml, ml – Subsidy by endorsement .................... 1.4 (33.90) a) Only on a PSO b) PSO must be endorsed “not for anaesthetic procedures”. LORATADINE ❋ Tab 10 mg ................................................................................ 8.50 10 ✔ Primoteston ✔ Vaxigrip

1 1 1 1 10

✔ RMS ✔ RMS ✔ RMS ✔ RMS

108

Diazemuls

144

✔ Loraclear Hayfever Relief

145

SALMETEROL – See prescribing guideline Aerosol inhaler, 5 µg per dose .............................................. .4 10 dose OP ✔ Serevent Note: this product has been replaced by Serevent aerosol inhaler CFC-free SALBUTAMOL Nebuliser soln, 1 mg per ml, .5 ml – Available on a PSO .......... .70 (4.8) Nebuliser soln, mg per ml, .5 ml – Available on a PSO .......... .85 (5.10) 0 Ventolin Nebules 0 Ventolin Nebules

177

AMINOACID FORMULA WITHOUT VALINE, LEUCINE AND ISOLEUCINE – Special Authority see SA07 – Hospital pharmacy [HP] See prescribing guideline Powder ................................................................................. 487.8 500 g OP ✔ MSUD Aid III

Effective 1 September 2007

HYOSCINE N-BUTYLBROMIDE ❋ Tab 10 mg ............................................................................... .5 (10.85) 100 Buscopan

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 September 2007 (continued)

5 LISINOPRIL ❋ Tab 5 mg ................................................................................. .78 (4.91) ❋ Tab 10 mg ............................................................................... .1 (7.14) ❋ Tab 0 mg ............................................................................... .91 (10.10) 0 Prinivil 0 Prinivil 0 Prinivil

CEFTRIAXONE SODIUM – Hospital pharmacy [HP] – Subsidy by endorsement a) Available on a PSO b) Subsidised only if prescribed for a dialysis or cystic fibrosis patient, or the treatment of confirmed ciprofloxacin-resistant gonorrhoea, or the treatment of suspected meningitis in patients who have a known allergy to penicillin, and the prescription or PSO is endorsed accordingly. Inj 50 mg ................................................................................ 4.00 1 ✔ Rocephin IV ACICLOVIR ❋ Tab dispersible 00 mg ............................................................ 7.9 (10.00) 7.1 (48.75) ❋ Tab dispersible 400 mg .......................................................... 8.4 (.00) ❋ Tab dispersible 800 mg .......................................................... 1.09 (.70) VALACICLOVIR Tab 500 mg ............................................................................. 1.58 (54.) 4.74 (1.80) PAROXETINE HYDROCHLORIDE Tab 0 mg ............................................................................... 5.90 (5.0) 100 Acicvir 90 Zovirax 40 Acicvir 100 Acicvir 10 Valtrex 0 Valtrex 0 Aropax ✔ Zyprexa ✔ Zyprexa ✔ Zyprexa

107

OLANZAPINE – Special Authority see SA0741– Retail pharmacy Tab .5 mg ............................................................................ 54.7 0 Tab 5 mg ............................................................................. 108.44 0 Tab 10 mg ........................................................................... 19.10 0 Note – Zyprexa tab 2.5 mg, 5 mg and 10 mg 28 tablet pack size is still subsidised. TRIFLUOPERAZINE HYDROCHLORIDE Tab 5 mg ................................................................................ 15.79 (17.77) 11

117

Stelazine Section 9 S29 10 Leucovorin 5 ml OP ✔ Alphagan

CALCIUM FOLINATE Tab 15 mg – PCT – Hospital pharmacy [HP]-Specialist .......... 8.90 (55.0) BRIMONIDINE TARTRATE – Retail pharmacy-Specialist ❋ Eye Drops 0.% ........................................................................ 8.95

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 September 2007 (continued)

175 GLUTEN FREE BREAD MIX – Special Authority see SA07 – Hospital pharmacy [HP] Powder ..................................................................................... 4.77 1,000 g OP (7.)

Bakels Gluten Free Bread Mix

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 January 2008

9 METFORMIN HYDROCHLORIDE ❋ Tab 500 mg ............................................................................. 9.75 ❋ Tab 850 mg ............................................................................. 8.00 DEXTROSE WITH ELECTROLYTES Soln with electrolytes ................................................................ . (.44) .0 (.) INFLUENZA VACCINE – Hospital pharmacy [Xpharm] Inj.......................................................................................... 7.50 500 50 500 ml OP Plasma-Lyte Oral 94 ml OP Pedialyte - Fruit 1 ✔ Fluvax ✔ Metomin ✔ Metomin

Effective 1 February 2008

44 8 ASPIRIN ❋ Tab 100 mg ............................................................................. .0 90 ✔ Ethics Aspirin EC

AZITHROMYCIN – Subsidy by endorsement a) Maximum of tab per prescription b) Available on a PSO c) Subsidised only if prescribed for patients with uncomplicated urethritis or cervicitis proven or presumed to be due to Chlamydia trachomatis and their sexual contacts and prescription or PSO is endorsed accordingly. Tab 500 mg ............................................................................. 9.90 OP (15.5) Zithromax METHADONE HYDROCHLORIDE a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets). d) For methadone hydrochloride oral liquid refer, page 159 Tab 5 mg ................................................................................. .10 10 (.78) Pallidone

104

Effective 1 March 2008

8 INSULIN ISOPHANE WITH INSULIN NEUTRAL ▲ Inj human with neutral insulin 100 u per ml .............................. 5. ▲ Inj human with neutral insulin 100 u per ml, ml ..................... 4. LACTULOSE – Only on a prescription ❋ Oral liq 10 g per 15 ml .............................................................. .0 ACEBUTOLOL ❋ Tab 400 mg ............................................................................ 7. 10 ml OP 5 ✔ Mixtard 50 ✔ PenMix 10 ✔ PenMix 20 ✔ Laevolac ✔ ACB

4 55

1,000 ml 100

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be delisted - effective 1 March 2008 (continued)

5 POVIDONE IODINE Oint 10% ................................................................................... .88 .87 (7.0) a) Maximum of 100 g per prescription b) Only on a prescription Antiseptic soln 10% .................................................................. .4 4.0 PIMOZIDE – Retail pharmacy-Specialist Tab 4 mg ............................................................................... 11.78 LORATADINE ❋ Tab 10 mg ............................................................................... .58 (.70) IPRATROPIUM BROMIDE Aqueous nasal spray, 0.0% .................................................... . (11.79) 5 g OP 100 g OP ✔ Biocil Betadine 500 ml 5,000 ml ✔ Biocil ✔ Biocil

0 100

✔ Orap Forte S29

144

Apo-Loratadine 15 ml OP Atrovent Nasal Aqueous

148

Effective 1 April 2008

5 SULPHASALAZINE Enema g per 100 ml - Retail pharmacy - Specialist ............... 7.40 (4.00) DEXTROSE ❋ Inj 50%, 10 ml – Available on a PSO .......................................... 8.5 BENZATHINE BENZYLPENICILLIN Injection 1. mega u – Available on a PSO ............................ 10.00 7 Salazopyrin 5 10 ✔ Mayne ✔ Pan Benzathine Benzylpenicillin

4 87

IBUPROFEN – Additional subsidy by Special Authority see SA091 – Retail pharmacy ❋ Tab 00 mg ............................................................................. 5. 100 (.80)

Brufen

99 11

TENOXICAM – Additional subsidy by Special Authority see SA091 – Retail pharmacy ❋ Inj 10 mg per ml, ml – Available on a PSO ............................ 10.00 5 ✔ Tilcotil DIMENHYDRINATE ❋ Tab 50 mg ............................................................................... 0.59 (.07) THIORIDAZINE HYDROCHLORIDE Tab 50 mg ............................................................................. 10. PILOCARPINE ❋ Eye drops % ........................................................................... .41 10 Dramamine 90 15 ml OP ✔ Aldazine ✔ Pilopt

117 15

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be delisted - effective 1 April 2008 (continued)

180 SOYA INFANT FORMULA – Special Authority see SA004 – Retail pharmacy Powder ..................................................................................... .4 900 g OP (18.)

Infasoy

Effective 1 May 2008

47 WATER 1) On a prescription or Practitioner’s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or ) On a bulk supply order; or ) When used in the extemporaneous compounding of eye drops. Purified for inj 5 ml – Available on a PSO ................................... 9.1 50 ✔ AstraZeneca Purified for inj 10 ml – Available on a PSO ............................... 10.8 50 ✔ AstraZeneca RITONAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Oral liq 80 mg per ml ............................................................ 77.8 40 ml OP ✔ Norvir

95 104

151 10

Effective 1 June 2008

7 CALCIUM GLUCONATE ❋ Inj 10%, 10 ml ...................................................................... 10.99 50 ✔ Mayne Note – the 10 injection pack size of the Mayne brand of calcium gluconate inj 10%, 10 ml was listed 1 December 007. ECONAZOLE NITRATE Crm 1% ..................................................................................... 1.00 (1.0) ERYTHROMYCIN LACTOBIONATE Inj 1g ........................................................................................ .50 Note – the Erythrocin IV brand was listed 1 December 007 MITOZANTRONE – PCT only – Specialist Inj mg per ml, 10ml ........................................................... 0.00 15 g OP Ecreme 1 ✔ ERA

✔ Onkotrone

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be delisted - effective 1 September 2008

95 SAQUINAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Cap 00 mg ......................................................................... 71.00 180 ✔ Fortovase

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 December 2007

CALCIUM GLUCONATE Inj 10%, 10 ml ................................Mayne 1.40 Inj 10%, 10 ml ................................Mayne 10.99 Note – Mayne, 50 inj pack size delisted 1 December 2007 CEFOXITIN SODIUM (ê price) Powder for inj 1 g ...........................Mayne ERYTHROMYCIN LACTOBIONATE Inj 1 g.............................................Erythrocin IV Inj 1 g.............................................ERA Note – ERA inj 1 g delisted 1 December 007 MITOZANTRONE Inj mg per ml, 5 ml ......................Mitozantrone Ebewe Inj mg per ml, 10 ml ....................Mitozantrone Ebewe 48.48 .50 .50 10 50

5 1 1

110.00 0.00

1 1

1% 1%

Feb-08 Feb-08

Onkotrone Mayne Novatrone Onkotrone

Note – Onkotrone inj mg per ml, 10 ml to be delisted 1 February 008 NAPROXEN SODIUM Tab 75 mg....................................Sonaflam 6.00 120 1% Feb-08 Synflex

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A ACB ................................................................... 7 Acebutolol.......................................................... 7 Acetopt .............................................................. 9 Acetylcysteine........................................ 18, 7, 9 Aciclovir ...................................................... , 5 Acicvir ............................................................... 5 Adrenaline.......................................................... Aldazine ....................................................... , 8 Alphagan ........................................................... 5 Alprazolam ......................................................... 17 Aminoacid formula without valine, leucine and isoleucine ................................................. 4 Apo-Captopril ..................................................... 8 Apo-Doxazosin................................................... 18 Apo-Ipravent ...................................................... 19 Apo-Loratadine ............................................ 7, 8 Apo-Oxybutynin ................................................. 9 Apo-Timop......................................................... 4 Aropax ............................................................... 5 Arrow-Alprazolam .............................................. 17 Arrow-Azithromycin ........................................... 0 Asacol ............................................................... 8 Aspirin ......................................................... 17, 7 Atrovent Nasal Aqueous ............................... 7, 8 Azithromycin .......................................... 0, 7, 7 B Bakels Gluten Free Bread Mix ............................. Bakels Gluten Free Health Bread Mix ................... 8 Benzathine benzylpenicillin ................................. 8 Betadine................................................. 7, 9, 8 Betaferon ........................................................... 0 Betagan ............................................................. 4 Betaloc CR ................................................... , 9 Betaxolol hydrochloride ...................................... 4 Betoptic ............................................................. 4 Betoptic S .......................................................... 4 Biocil ................................................................. 8 Brimonidine tartrate ...................................... 4, 5 Brimonidine tartrate with timolol maleate............. 4 Brufen.................................................... 19, , 8 Brufen Retard ..................................................... Budesonide with eformoterol .............................. 19 Buscopan .......................................................... 4 C Calcium folinate ................................................. 5 Calcium gluconate ................................. 17, 9, 41 Calogen ............................................................. Captopril ............................................................ 8 Carbosorb .......................................................... Cefoxitin sodium .......................................... 7, 41 Ceftriaxone sodium ............................................ 5 Cellcept ............................................................. Cetomacrogol .................................................... Charcoal ............................................................ Ciloxan............................................................... Ciprofloxacin ...................................................... Citalopram - Rex ................................................ 19 Citalopram hydrobromide ................................... 19 Colestid ............................................................. 8 Colestipol hydrochloride ..................................... 8 Colifoam ............................................................ Colistin-Link ....................................................... 9 Colistin sulphomethate ....................................... 9 Combigan .......................................................... 4 Condoms without spermicide ............................. Cosopt ............................................................... 4 D De-nol................................................................ Dexamethasone ................................................. 4 Dexamethasone with framycetin and gramicidin ................................................ Dexamethasone with neomycin and polymyxin b sulphate ...................................... 4 Dextrose ............................................................ 8 Dextrose with electrolytes............................. 8, 7 Diazemuls .......................................................... 4 Diazepam..................................................... 8, 4 Diclofenac sodium ............................................. 4 Digoxin .............................................................. 8 Dimenhydrinate .................................................. 8 Dorzolamide hydrochloride ................................. 4 Dorzolamide hydrochloride with timolol maleate................................................ 4 Doxazosin mesylate ........................................... 18 Dramamine ........................................................ 8 Dr Reddy’s Omeprazole...................................... 18 Duphalac ........................................................... 18 E Econazole nitrate ................................................ 9 Ecreme .............................................................. 9 Eloxatin .............................................................. 1 Eltroxin .............................................................. 9 ERA ............................................................. 9, 41 Erythrocin IV ................................................ 17, 41 Erythromycin lactobionate ...................... 17, 9, 41 Ethics Aspirin EC.......................................... 17, 7 F Fat ..................................................................... 5 Fat supplement .................................................. Ferodan ............................................................. 17 Ferrous sulphate ................................................ 17 Flucon................................................................ 4 Fluorometholone ................................................ 4

Index

Pharmaceuticals and brands Fluvax ................................................................ 7 Fortovase ........................................................... 40 Fucidin ............................................................... 9 Fusidic acid........................................................ 9 G Genoptic ............................................................ Gentamicin sulphate ........................................... Gluten free bread mix ................................... 8, Gluten free flour ................................................. 8 H Horleys Bread Mix .............................................. 8 Horleys Flour...................................................... 8 Hydrocortisone acetate ...................................... Hydrocortisone butyrate ..................................... 0 Hyoscine N-butylbromide ................................... 4 I Ibuprofen ............................................... 19, , 8 Infasoy .............................................................. 9 Influenza vaccine.......................................... 4, 7 Insulin isophane with insulin neutral.................... 7 Interferon beta-1-beta......................................... 0 Invirase .............................................................. 17 Ipratropium bromide ............................... 19, 7, 8 L Lactulose ..................................................... 18, 7 Laevolac ............................................................ 7 Lanoxin .............................................................. 8 Lanoxin PG ........................................................ 8 Leucovorin ......................................................... 5 Levobunolol ....................................................... 4 Lisinopril ............................................................ 5 Lithium carbonate .............................................. 0 Locoid ............................................................... 0 Lopresor ............................................................ 9 Loraclear Hayfever Relief.............................. 19, 4 Loratadine........................................ 19, 7, 4, 8 M Macrogol 50 .................................................. 19 Malathion ..................................................... 0, Maxidex ............................................................. 4 Maxitrol.............................................................. 4 Mesalazine ................................................... 18, 8 Metformin hydrochloride .............................. 0, 7 Methadone hydrochloride ........... 18, 0, 7, 7, 9 Metomin ...................................................... 0, 7 Metoprolol succinate .................................... , 9 Metoprolol tartrate .............................................. 9 Midazolam ......................................................... 19 Minims .............................................................. 5 Mitozantrone .................................... 17, 7, 9, 41 Mitozantrone Ebewe ..................................... 17, 41 Mixtard 50 ......................................................... 7 Morphine sulphate.............................................. 4 Movicol.............................................................. 19 MSUD Aid III ...................................................... 4 Mycophenolate mofetil ....................................... N Naproxen sodium ......................................... 17, 41 Nepro (vanilla) ................................................... Nifuran ............................................................... 0 Nitrofurantoin ..................................................... 0 Norvir .......................................................... 18, 9 NZB Low Gluten Bread Mix ................................. 8 O Olanzapine ......................................................... 5 Omeprazole........................................................ 18 Ondansetron ...................................................... Onkotrone .......................................................... 9 Orap Forte .......................................................... 8 Oxaliplatin .......................................................... 1 Oxybutynin ......................................................... 9 Oxycodone hydrochloride ............................. 0, OxyNorm ..................................................... 0, P Paclitaxel ..................................................... 1, 0 Paclitaxel Ebewe ................................................ 1 Paediatric products ............................................ 5 Pallidone ...................................................... 7, 7 Pan Benzathine Benzylpenicillin .......................... 8 Paroxetine hydrochloride .................................... 5 Parvolex ............................................................. 9 Pedialyte - Fruit ............................................ 8, 7 PenMix 10 ......................................................... 7 PenMix 0 ......................................................... 7 Pentasa ............................................................. 18 Peptisoothe ........................................................ 17 Phenoxymethylpenicillin (Penicillin V) ........... , 9 Phenylephrine hydrochloride .............................. 0 Pilocarpine ................................................... 5, 8 Pilopt ................................................................. 8 Pimozide ............................................................ 8 Plasma-Lyte Oral.......................................... 8, 7 Povidone iodine ..................................... 7, 9, 8 Pred Forte .......................................................... 4 Pred Mild ........................................................... 4 Prednisolone acetate .......................................... 4 Prefrin................................................................ 0 Premature birth formula...................................... Priadel ............................................................... 0 Primoteston ....................................................... 4 Prinivil................................................................ 5 Q Quetapel ............................................................ 18 Quetiapine.............................................. 18, , 0

Index

Pharmaceuticals and brands R R Superfeucht .................................................. Ranitidine hydrochloride ..................................... 17 Renal oral feed kcal/ml ..................................... Riodine .............................................................. 7 Ritonavir ...................................................... 18, 9 Rocephin IV ....................................................... 5 S SLBW Gold .................................................... S Soy............................................................. 19 Salazopyrin ........................................................ 8 Salbutamol......................................................... 4 Salmeterol ......................................................... 4 Saquinavir .................................................... 17, 40 Serevent ............................................................ 4 Seroquel ...................................................... , 0 Similac Special Care .......................................... SimvaRex .......................................................... 19 Simvastatin ........................................................ 19 Sodium chloride ................................................. 18 Sodium citro-tartrate .......................................... Sofradex ............................................................ Sonaflam ..................................................... 17, 41 Soya infant formula ...................................... 19, 9 Stelazine Section 29 ........................................... 5 Stesolid ............................................................. 8 Sulphacetamide sodium ..................................... 9 Sulphasalazine ................................................... 8 Surgam SA ........................................................ 4 Symbicort Rapihaler ........................................... 19 T Taxol ........................................................... 1, 0 Tenoxicam ......................................................... 8 Testosterone enanthate ...................................... 4 Thioridazine hydrochloride............................ , 8 Thyroxine ........................................................... 9 Tiaprofenic acid ................................................. 4 Tilcotil ................................................................ 8 Timolol maleate.................................................. 4 Timoptol XE ....................................................... 4 Tobramycin........................................................ 4 Tobrex ............................................................... 4 Trifluoperazine hydrochloride .............................. 5 Tripotassium dicitratobismuthate ........................ Trusopt .............................................................. 4 U Ural.................................................................... V Valaciclovir ........................................................ 5 Valtrex ............................................................... 5 Vaxigrip ............................................................. 4 Ventolin Nebules ................................................ 4 Vinorelbine ......................................................... Vinorelbine Ebewe .............................................. Voltaren Ophtha ................................................. 4 W Water ........................................................... 0, 9 Z Zithromax..................................................... 7, 7 Zofran ................................................................ Zofran Zydis ....................................................... Zovirax ......................................................... , 5 Zyprexa .............................................................. 5

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update. Pharmaceutical Management Agency Level 14 Cigna House, 40 Mercer Street PO Box 10 254 Wellington, New Zealand Telephone 64 4 460 4990 Facsimile 64 4 460 4995 Freephone information line (9am - 5pm weekdays) 0800 66 00 50 www.pharmac.govt.nz

Metadata

Title

Schedule Update - effective 1 Dec 2007

Abstract

07 UPDATE New Zealand Pharmaceutical Schedule Effective 1 December 2007 Cumulative for September, October, November and December 2007 Section H cumulative for December 2007 Contents Summary of PHARMAC decisions effective 1 December 2007 …. .3 Wider access to some Pharmaceutical…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.